Akonni Biosystems in Frederick, Maryland, received a U.S. patent for its “Apparatus, system, and method for purifying nucleic acids” technology, which applies to its nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification.
According to Akonni Biosystems, this technology can reduce to a few minutes the time needed to obtain polymerase chain reaction (PCR)-ready material from clinical specimens — a 10-fold or greater decrease. The company says the faster extraction of nucleic acids can apply to identification of influenza and cancer markers, genetics research, drug discovery, and forensics cases.
The technology is available in Akonni Biosystems’ TruTip Extraction Kits, which were first released to the market last November. The company estimates the size of the nucleic acid extraction market at about $700 million.
RSS - Posts